Neuroendocrine tumor imaging: Can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior?

World Journal of Surgery

Volumn 22, Issue 6, 1998, Pages 588-592

  Pasquali, Claudio ^a   Rubello, Domenico ^b   Sperti, Cosimo ^a   Gasparoni, Piero ^b   Liessi, Guido ^b   Chierichetti, Franca ^b   Ferlin, Giorgio ^b   Pedrazzoli, Sergio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AGGRESSION; BRAIN SCINTISCANNING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ENHANCEMENT; ISOTOPE LABELING; MALE; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; TUMOR LOCALIZATION;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031900605     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900439     Document Type: Conference Paper

References (14)

1. 111In-DTPA-D-Phe] and [123-Try3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20:716, 1993
2. Krenning, E.P., Kwekkboom, D.J., Oei, H.Y., de Jong, R.J.B., Dop, F.J., Reubi, J.C., Lamberts, S.W.J.: Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors: an overview of European results. Ann. N.Y. Acad. Sci. 733:416, 1994
3. Meko, J.B., Doherty, G.M., Siegel, B.A., Norton, J.A.: Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors. Surgery 120:975, 1996
4. Strauss, L.G., Conti, P.S.: The application of PET in clinical oncology. J. Nucl. Med. 32:623, 1991
5. Hawkins, R.A.: Pancreatic tumors: imaging with PET. Radiology 195:320, 1995
6. Bares, R., Klever, P., Hauptmann S., Hellwig, D., Fass, J., Cremerius, U., Schumpelick, V., Mittermayer, C., Bull U.: F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79, 1994
7. Stollfuss, J.C., Glatting, G., Friess, H., Kocher, F., Beger, H.G., Reske, S.N.: 2-(Fluorine-18)-fluoro-2-deoxyglucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 195:339, 1995
8. Inokuma, T., Tamaki, N., Torizuka T., Magata Y., Fujii, M., Yonekura, Y., Kajiyama, T., Ohshio, G., Imamura, M., Konishi J.: Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 195:345, 1995
9. Pasquali, C., Rubello, D., Sperti, C., Zanco, P., Liessi, G., Chierichetti, F., Pedrazzoli, S., Ferlin, G.: 18-FDG-PET imaging in the diagnosis of pancreatic diseases [abstract]. HPB 1(Suppl 1):187, 1997
10. 18F-Fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer 79:695, 1997
11. Kloppel, G., Heitz, P.U.: Classification of normal and neoplastic neuroendocrine cells. Ann. N.Y. Acad. Sci. 733:19, 1994
12. La Rosa, S., Sessa, F., Capella, C., Riva, C., Leone, B.E., Klersy, C., Rindi, G., Solcia E.: Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 429:323, 1996
13. Eriksson, B., Bergstrom, M., Lilja, A., Ahlstrom, H., Langstrom, B., Oberg, K.: Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncol. 32:189, 1993
14. Ahlstrom, H., Eriksson, B., Bergstrom, M., Bjurling, P., Langstrom, B., Oberg, K.: Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 195:333, 1995